Fibrinolysis inhibitors

Fibrinolysis inhibitors inhibit fibrinolysis by competitive inhibition of the plasminogen-activating enzyme and inhibition of plasmin formation (aminocaproic acid, aminomethylbenzoic acid, etc.) or by complexing with plasmin (aprotinin). Regardless of the mechanism of inhibition of fibrinolysis, they have a specific hemostatic effect in various pathological conditions in which the fibrinolytic activity of blood and tissues is increased, as well as during surgical operations.
Below is a list of fibrinolysis inhibitors:

  • Aminomethylbenzoic acid (Acidum aminomethylbenzoicum)
  • Aminocaproic acid
  • Aprotinin
  • Tranexamic acid